A new analysis of federal data by HealthCare.com shows the average cost of treating disease in the United States rose 60% from 1999 to 2022.
The Bureau of Labor Statistics tracks the costs to treat 115 diseases that make up its Disease Based Price Indexes. While many diseases have grown much costlier to treat, others have actually gotten cheaper.
Above, explore changes in treatment costs, defined as “the average expenditure for all medical services used to treat a specific medical condition.” Below, read our findings on which diseases have gotten pricier to heal, which have gotten cheaper, and why these changes have occurred.
Key Findings
Among the diseases that make up the index, intestinal infections, including common bugs like E. coli, have seen the most growth in treatment cost. The price to treat intestinal infections rose 4.3 times by 2022 against the base index of 1 in 1999, jumping from an average of $134 to $570.
“This is consistent with more severe infections becoming relatively more common,” explains Brett Matsumoto, a research economist at the Bureau of Labor Statistics. “For intestinal infections, the increase in utilization appears to be driven by an increase in inpatient hospitalizations and emergency room visits.”
The top five diseases to see the greatest percentage growth in cost include:
Three out of five diseases to see the greatest percent growth are conditions of the digestive system.
Diabetes with complications saw the most decline in treatment cost. Along with other conditions grouped with diabetes, the disease plunged almost 80% in cost to treat by 2022. In dollar terms, that’s a drop from $1,424 to $314 to manage one of the world’s most common illnesses.
Various factors can drive cost declines. One key element is lower utilization of healthcare services and drugs for the average case.
“This can be due to the average case becoming less severe over time,” Matsumoto says. “For example, if minor cases are more likely to be diagnosed and receive treatment, then the average utilization for those who receive treatment decreases, and the disease-based price indexes show this as a price decline.”
It’s also possible that treatments could become less intensive due to technological advances leading to treatments being performed in less intensive settings, such as inpatient instead of outpatient.
It can also be the case, Matsumoto notes, that changes in medical coding over time can shift the average severity of a particular diagnosis. For example, an individual who used to be diagnosed with diabetes without complications is later diagnosed as having diabetes with complications.
“Milder cases lead to less intensive treatments,” describes Harvard health economist David Cutler, who also served as Senior Health Care Advisor for the Obama Presidential Campaign. “On a population basis total spending is going up significantly, but on an individual basis you have people who are not using that much medicine or treatment.”
The five diseases that dropped the most by percent in cost to treat are:
Two out of five are circulatory illnesses, another involves blood, while diabetes is also a risk factor for circulatory disease.
“The number of people having heart attacks and strokes is way down,” Cutler says. “Part of that is because we have much better preventive care. That’s a huge factor in medical care: the ability to prevent and treat cardiovascular events. And that’s having a huge effect on spending.”